Source: Virtual Congress 2021 – COVID - 19 biomarkers



Rating:

Share or cite this content

Citations should be made in the following way:
M. Krykhtina (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine). The best coagulation marker for prediction of COVID-19 pneumonia progression.. 649

Member's Comments

No comment yet.

Related content which might interest you: What is the best biomarker of COVID-19 pneumonia progression? Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 D-dimer is an independent marker predicting severity in community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Fibrinogen like the predictor of COVID-19 pneumonia progression Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 A basic prediction model with clinical parameters to diagnose lung cancer. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Determining the best diagnostic biomarker for sepsis and prognosis assessment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia. Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 The best predictor of COVID-19 pneumonia progression during lung ultrasound (LUS) Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Procalcitonin and C reactive protein as markers of treatment failure in community-acquired pneumonia Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018 Year: 2018 The role of serum inflammatory markers in the detection of ventilation associated pneumonia (VAP) Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 The value of immunological methods in the complex diagnostics of TB in chronic renal failure patients in the terminal stage Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Incidence of ventilator associated pneumonia (VAP) and assessment of serial estimation of procalcitonin levels as a prognostic marker in cases of VAP in a tertiary centre in India Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Which is the most effective inflammatory marker in the diagnosis, severity and treatment follow-up of patients with pneumonia? Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Platelet-to-lymphocyte ratio (PLR) as a predictor of Covid-19 pneumonia progression Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Thrombin generation test – As a potential marker of severity and outcome of severe pneumonia with pulmonary sepsis Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 327s Year: 2006 Platelet count as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019